Comprehensive analysis of acetylcholinesterase inhibitor and reactivator complexes: implications for drug design and antidote development

Weronika Bagrowska,Angelika Karasewicz,Artur Góra
DOI: https://doi.org/10.1016/j.drudis.2024.104217
IF: 8.369
2024-10-31
Drug Discovery Today
Abstract:The main function of acetylcholinesterase (AChE) is to regulate the levels of one of the most important neurotransmitters: acetylcholine. This makes AChE an ideal molecular target for the treatment of neurodegenerative diseases and dementia (such as Alzheimer's disease), as well as for the neutralisation of natural toxins (e.g., venom peptides) and chemical warfare agents. The significance of AChE inhibitors in slowing the progression of dementia, as well as the role of reactivators in treating...
pharmacology & pharmacy
What problem does this paper attempt to address?